Prognostic Value of Primary Tumor Sidedness in Patients With Nonmetastatic IBD-Related CRC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Surgical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC - Is it the exception to the rule?
Surg Oncol 2022 Dec 01;45(xx)101874, C Kamphues, JH Lefevre, J Wang, N Amini, L Beaugerie, F Kuehn, SH Park, N Andreatos, JC Lauscher, D Enea, KS Lehmann, N Peru, B Weixler, J Kirchgesner, CE Degro, I Pozios, CJ van Beekum, S Schölch, D Zambonin, C Schineis, FN Loch, D Geka, M Theoxari, B Wu, PP Wang, E Antoniou, E Pikoulis, D Moussata, G Theodoropoulos, M Ouaissi, H Seeliger, Y Inaba, S Scaringi, C Reißfelder, TO Vilz, C Lin, SK Yang, K Beyer, BW Renz, K Sasaki, GA Margonis, M Svrcek, ME KreisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.